| Quarter (USD) | Oct 24 | Jul 24 | Apr 24 | Jan 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Oct 24 | Oct 23 | |
|---|---|---|---|
| Revenue | |||
| Cost of revenue | |||
| Operating income | |||
| Operating margin | |||
| Net income | |||
| Net profit margin | |||
| Cash on hand | |||
| Change in cash | |||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 173.00 mm | 173.00 mm | 173.00 mm | 173.00 mm | 173.00 mm | 173.00 mm |
| Cash burn (monthly) | 28.22 mm | (no burn) | 5.82 mm | 5.19 mm | 6.52 mm | 4.02 mm |
| Cash used (since last report) | 117.73 mm | n/a | 24.27 mm | 21.65 mm | 27.21 mm | 16.78 mm |
| Cash remaining | 55.27 mm | n/a | 148.73 mm | 151.35 mm | 145.80 mm | 156.22 mm |
| Runway (months of cash) | 2.0 | n/a | 25.6 | 29.2 | 22.4 | 38.8 |
| 13F holders | Current |
|---|---|
| Total holders | 40 |
| Opened positions | 33 |
| Closed positions | 0 |
| Increased positions | 2 |
| Reduced positions | 2 |
| 13F shares | Current |
|---|---|
| Total value | 274.85 bn |
| Total shares | 58.54 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| FCPM Iii Services B.V. | 9.63 mm | $64.06 bn |
| VR Adviser | 5.05 mm | $33.56 bn |
| Venrock Healthcare Capital Partners III | 5.05 mm | $35.83 mm |
| Kynam Capital Management | 4.99 mm | $33.21 bn |
| Deep Track Capital | 4.56 mm | $30.31 bn |
| Lumira Capital Investment Management | 4.18 mm | $74.44 mm |
| Blue Owl Capital | 3.16 mm | $21.01 bn |
| Biotechnology Value Fund L P | 3.05 mm | $21.67 mm |
| Cormorant Asset Management | 2.32 mm | $15.45 bn |
| BVF | 2.11 mm | $14.01 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 29 Jan 25 | Cooper Ronald Harold Wilfred | Stock Option Common Shares | Grant | Acquire A | No | No | 7.39 | 850,000 | 6.28 mm | 850,000 |
| 29 Jan 25 | Anthony Tzeyew Cheung | Stock Option Common Shares | Grant | Acquire A | No | No | 7.39 | 250,000 | 1.85 mm | 250,000 |
| 29 Jan 25 | D. Ryan Daws | Stock Option Common Shares | Grant | Acquire A | No | No | 7.39 | 280,000 | 2.07 mm | 280,000 |
| 29 Jan 25 | Lee Giguere | Stock Option Common Shares | Grant | Acquire A | No | No | 7.39 | 250,000 | 1.85 mm | 250,000 |
| 29 Jan 25 | Alexander Julian Nichols | Stock Option Common Shares | Grant | Acquire A | No | No | 7.39 | 250,000 | 1.85 mm | 250,000 |
